1.
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
by CAMERON, N. E
Diabetologia, 2001, Vol.44 (11), p.1973-1988
2.
Effects of diabetes and treatment with the antioxidant α-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats
by KEEGAN, A
Diabetologia, 1999, Vol.42 (3), p.343-350
3.
Effects of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes
by CAMERON, N. E
Diabetologia, 2001, Vol.44 (9), p.1161-1169
4.
Protein kinase C effects on nerve function, perfusion, Na+, K+-ATPase activity and glutathione content in diabetic rats
by CAMERON, N. E
Diabetologia, 1999, Vol.42 (9), p.1120-1130
5.
Effects of α-lipoic acid on neurovascular function in diabetic rats : interaction with essential fatty acids
by CAMERON, N. E
Diabetologia, 1998, Vol.41 (4), p.390-399
6.
Effects of an extracellular metal chelator on neurovascular function in diabetic rats
by CAMERON, N. E
Diabetologia, 2001, Vol.44 (5), p.621-628
7.
8.
An in vitro investigation of aorta and corpus cavernosum from eNOS and nNOS gene-deficient mice
by Nangle, M R
Pflügers Archiv, 2004-05, Vol.448 (2), p.139-145
9.
Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta
by KEEGAN, A
Diabetologia, 1995, Vol.38 (12), p.1475-1478
10.
Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats : role of polyol pathway
by COMERON, N. F
Diabetologia, 1992, Vol.35 (11), p.1011-1019
11.
Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats
by CAMERON, N. E
Diabetologia, 1994, Vol.37 (5), p.449-459
12.
Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats
by CAMERON, N. E
Diabetologia, 1996, Vol.39 (2), p.172-182
13.
Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats
by COTTER, M. A
Diabetologia, 1995, Vol.38 (11), p.1285-1294
14.
Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats
by CAMERON, N. E
Diabetologia, 1993, Vol.36 (4), p.299-304
15.
Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats
by CAMERON, N. E
Diabetologia, 1992, Vol.35 (10), p.946-950
16.
Angiotensin converting enzyme inhibition prevents in development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats
by CAMERON, N. E
Diabetologia, 1992, Vol.35 (1), p.12-18
17.
18.
The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats
by CAMERON, N. E
Diabetologia, 1994, Vol.37 (12), p.1209-1215
19.
20.
Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function
by MAXFIELD, E. K
Diabetologia, 1993, Vol.36 (12), p.1230-1237
